This inventor holds 2 USPTO granted patents and 4 EPO patents. Top assignees: Hanlim Pharmaceutical Co., Ltd., Catholic University Academic Cooperation Foundation. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: The Innovative Contributions of Byong-Sun Choi in Pharmaceutical Research
Introduction
Byong-Sun Choi, based in Seoul, South Korea, is a prominent inventor with notable contributions to the field of pharmaceuticals. With a total of two patents to his name, Choi's innovations focus primarily on compositions that aim to improve health outcomes for patients suffering from various conditions.
Latest Patents
Choi's recent patents showcase his commitment to advancing medical treatments. The first patent is a pharmaceutical composition designed for the prevention or treatment of osteoarthritis, which utilizes rebamipide as the active ingredient. This invention outlines a method of administering rebamipide, either as a standalone treatment or within a pharmaceutical composition, formulated for convenient oral delivery. The dosage is meticulously detailed, with optimal ranges from 0.5 to 50 mg/kg, emphasizing the precision required in pharmaceutical advancements.
The second patent features a pharmaceutical composition intended for nasal administration, combining mometasone furoate and azelastine hydrochloride. A unique aspect of this formula is the inclusion of thaumatin, an agent that mitigates bitterness and irritation, making it more palatable for patients. This innovation addresses both efficacy and user experience, showcasing Choi's holistic approach to pharmaceutical solutions.
Career Highlights
Throughout his career, Byong-Sun Choi has worked with notable organizations such as Hanlim Pharmaceutical Co., Ltd. and the Catholic University Academic Cooperation Foundation. His experiences at these institutions have significantly influenced his research and approach to developing innovative pharmaceutical products.
Collaborations
In his journey of innovation, Choi has collaborated with esteemed colleagues, including Geun-Hyeog Lee and Jin-Ha Park. These partnerships illustrate the collaborative spirit of research and development, which is critical to fostering significant advancements in the pharmaceutical industry.
Conclusion
Byong-Sun Choi is a noteworthy inventor whose work continues to shape the landscape of pharmaceutical research. With his innovative patents focusing on osteoarthritis and nasal administration formulations, Choi exemplifies the critical role of inventors in creating effective and user-friendly health solutions. His collaborations and career experiences further emphasize the importance of teamwork in the pursuit of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile